Evidence for an involvement of tachykinins in allodynia in streptozocin-induced diabetic rats

European Journal of Pharmacology

Volumn 401, Issue 1, 2000, Pages 47-53

  Coudoré Civiale, Marie Ange ^a   Courteix, Christine ^a   Boucher, Michel ^a   Fialip, Joseph ^a   Eschalier, Alain ^b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Allodynia, tactile; Allodynia, thermal; Diabetic, rat; Tachykinin receptor antagonist

Indexed keywords

2 [1 IMINO 2 (2 METHOXYPHENYL)ETHYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 ONE; NEUROKININ A; SAREDUTANT; SUBSTANCE P; TACHYKININ RECEPTOR ANTAGONIST;

ALLODYNIA; ANIMAL EXPERIMENT; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DIABETES MELLITUS; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ANALGESICS; ANIMALS; BENZAMIDES; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; INDOLES; MALE; PAIN; PAIN THRESHOLD; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROKININ-1; RECEPTORS, NEUROKININ-2; TACHYKININS; TEMPERATURE; TIME FACTORS;

EID: 0343526440     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00314-9     Document Type: Article

References (36)

1. Ahlgren S.C., Wang J.F., Levine J.D. C-fiber mechanical stimulus-response functions are different in inflammatory versus neuropathic hyperalgesia in the rat. Neuroscience. 76:1997;285-290.
2. Ahlgren S.C., White D.M., Levine J.D. Increased responsiveness of sensory neurons in the saphenous nerve of the streptozocin-diabetic rat. J. Neurophysiol. 68:1992;265-281.
3. Bennett G.J. Neuropathic pain. Wall P.D., Melzack R. Textbook of Pain. 3rd edn. 1994;201-224 Churchill Livingstone.
4. Brewster W.J., Diemel L.T., Leach R.M., Tomlison D.R. Reduced sciatic nerve substance P and calcitonin gene-related peptide in rats with short-term diabetes or central hypoxaemia co-exist with normal messenger RNA levels in the lumbar dorsal root ganglia. Neuroscience. 58:1994;323-330.
5. Calcutt N.A., Li L., Yaksh T.Y.L., Malberg A.B. Different effects of two aldose reductase inhibitors on nociception and prostaglandin E. Eur. J. Pharmacol. 285:1995;189-197.
6. Calcutt N.A., Jorge M.C., Yaksh T.L., Chaplan S.R. Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaïne. Pain. 68:1996;293-299.
7. Chapman V., Dickenson A.H. The effect of intrathecal administration of RP67580, a potent neurokinin 1 antagonist on nociceptive transmission in the rat spinal cord. Neurosci. Lett. 157:1993;149-152.
8. Coudoré-Civiale M.-A., Courteix C., Eschalier A., Fialip J. Effects of tachykinin receptor antagonists in experimental neuropathic pain. Eur. J. Pharmacol. 361:1998;175-184.
9. Courteix C., Eschalier A., Lavarenne J. Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain. Pain. 53:1993;81-88.
10. Devor M. Pain mechanisms. Neuroscientist. 2:1996;233-244.
11. Duggan A.W., Weihe E. Central transmission of impulses in nociceptors: events in the superficial dorsal horn. Basbaum A., Besson J.M. Towards a New Pharmacology of Pain. 1991;35-67 Wiley, Chichester.
12. 2) receptor. Life Sci. 50:1992;101-106.
13. 1 receptor during maintenance of mechanical hypersensitivity induced by diabetes in the rat. J. Pharmacol. Exp. Ther. 285:1998;1226-1232.
14. Garret C., Carruette A., Fardin V., Moussaoui S., Peyronel J.F., Blanchard J.C., Laduron P.M. RP 67580, a potent and selective non-peptide substance P antagonist. C. R. Acad. Sci. Paris. 314(3):1992;199-204.
15. Garrett N.E., Malcangio M., Dewhurst M., Tomlison D.R. α Lipoic acid corrects neuropeptide deficits in diabetic rats via induction of trophic support. Neurosci. Lett. 222:1997;191-194.
16. Hökfelt T., Zhang X., Wiesenfeld-Hallin Z. Messenger plasticity in primary sensory neurons following axotomy and its functional implications. Trends Neurosci. 17:1994;22-30.
17. Jirmanova I. Giant axonopathy in streptozocin diabetic rats. Acta Neuropathol. 86:1993;42-48.
18. Kamei J., Ogawa M., Kasuya Y. Development of supersensitivity to substance P in the spinal cord of the streptozocin-induced diabetic rats. Pharmacol. Biochem. Behav. 35:1990;473-475.
19. Kamei J., Ogawa M., Ohhashi Y., Kasuya Y. Alterations in the potassium-evoked release of substance P from the spinal cord of streptozocin-induced diabetic rats in vitro. Gen. Pharmacol. 22:1991;1093-1096.
20. Kastrup J., Petersen P., Dejgård A., Angelo H., Hilstead J. Intravenous lidocaine infusion: a new treatment of chronic painful diabetic neuropathy? Pain. 28:1987;69-75.
21. Lee J.H., McCarty R. Pain threshold in diabetic rats: effects of good versus poor diabetic control. Pain. 50:1992;231-236.
22. Leem J.W., Willis W.D., Chung J.M. Cutaneous sensory receptors in the rat foot. J. Neurophysiol. 69:1993;1684-1699.
23. Ma Q.-P., Woolf C.J. Involvement of neurokinin receptors in the induction but not the maintenence of mechanical allodynia in the rat flexor motoneurones. J. Physiol. 486:1995;769-777.
24. 2 receptor antagonist. Eur. J. Pharmacol. 234:1993;83-90.
25. Malcangio M., Tomlison D.R. A pharmacologic analysis of mechanical hyperalgesia in streptozocin/diabetic rats. Pain. 76:1998;151-157.
26. Malmberg A.B., Yaksh T.L., Calcutt N.A. Anti-nociceptive effects of the GM1 ganglioside derivative AGF 44 on the formalin test in normal and streptozotocin-diabetic rats. Neuroscience. 1993;45-48.
27. Mestre C., Pelissier T., Fialip J., Wilcox G., Eschalier A. A method to perform direct transcutaneous intrathecal injections in rats. J. Pharmacol. Toxicol. Methods. 32:1994;197-200.
28. Neumann S., Doubbell T.P., Leslie T., Woolf C.J. Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons. Nature. 384:1996;360-364.
29. Picard P., Boucher S., Regoli D., Gitter B.D., Howbert J.J., Couture R. Use of non-peptide tachykinin receptor antagonists to substantiate the involvement of NK1 and NK2 receptors in a spinal nociceptive reflex in the rat. Eur. J. Pharmacol. 232:1993;255-261.
30. 1 receptor antagonists: non-specific effects of racemic RP67580. Br. J. Pharmacol. 110:1993;1607-1613.
31. Sharma A.K., Thomas P.K. Peripheral nerve structure and function in experimental diabetes. J. Neurol. Sci. 23:1974;1-15.
32. Tamura E., Parry G.J. Severe radicular pathology in rats with longstanding diabetes. J. Neurol. Sci. 127:1994;29-35.
33. Watkins P.J. Natural history of the diabetic neuropathies. Q. J. Med. 284:1990;1209-1218. New Series.
34. Weihe E. Zenker W., Neuhuber W. Primary Afferent Neurones. 1990;127-159 Plenum, New York.
35. Willis W.D., Coggeshall R.E. Sensory Mechanisms of the Spinal Cord. 2nd edn. 1991;Plenum, New York, NY.
36. Yashpal K., Hui-Chan C.W.Y., Henry J.L. SR 48968 specially depresses neurokinin A- vs. substance P-induced hyperalgesia in a nociceptive withdrawal reflex. Eur. J. Pharmacol. 308:1996;41-48.